Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Escalada, J. (Javier) | - |
dc.date.accessioned | 2022-08-11T11:16:29Z | - |
dc.date.available | 2022-08-11T11:16:29Z | - |
dc.date.issued | 2022 | - |
dc.identifier.citation | Escalada-San Martín, F. (Francisco Javier). "SGLT2 inhibitors and the cardiorenal continuum: a paradigm shift in the treatment of patients with T2D". Diabetes therapy. 13 (Supl. 1), 2022, 1 - 3 | es |
dc.identifier.issn | 1869-6953 | - |
dc.identifier.uri | https://hdl.handle.net/10171/63907 | - |
dc.description.abstract | Type 2 diabetes mellitus (T2D) represents a sig- nificant public health problem, with a dramat- ically increasing prevalence. T2D is considered a progressive disease that develops macro- and microvascular complications such as cardiovas- cular disease (CVD), heart failure (HF), and chronic kidney disease (CKD), which are closely interconnected and constitute the main causes of morbidity and mortality in these patients. Over time, finding new pharmacological approaches to protect against these cardiorenal events (the ‘‘cardiorenal continuum’’) has become the fundamental objective of research aimed at these patients. | - |
dc.description.sponsorship | AstraZeneca funded the writing assistance provided by Springer Healthcare Ibe ́rica SL and the journal’s Rapid Service Fee. This supplement has been sponsored by AstraZeneca. | - |
dc.language.iso | en | - |
dc.rights | info:eu-repo/semantics/openAccess | - |
dc.subject | Type 2 diabetes | - |
dc.subject | SGLT2 inhibitors | - |
dc.subject | Cardiorenal | - |
dc.subject | Cardiovascular disease | - |
dc.subject | Kidney disease | - |
dc.subject | Heart failure | - |
dc.subject | Morbidity | - |
dc.subject | Mortality | - |
dc.subject | Chronic kidney disease | - |
dc.subject | Cardiorenal continuum | - |
dc.title | SGLT2 inhibitors and the cardiorenal continuum: a paradigm shift in the treatment of patients with T2D | - |
dc.type | info:eu-repo/semantics/article | - |
dc.relation.publisherversion | https://pubmed.ncbi.nlm.nih.gov/35704164/ | - |
dc.description.note | This article is licensed under a Creative Commons Attribution-NonCommer- cial 4.0 International License | - |
dc.identifier.doi | 10.1007/s13300-022-01281-5 | - |
dadun.citation.endingPage | S3 | - |
dadun.citation.publicationName | Diabetes therapy | - |
dadun.citation.startingPage | S1 | - |
dadun.citation.volume | 13 | - |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.